Strategies Combining Total and Percent Free Prostate Specific Antigen for Detecting Prostate Cancer: A Prospective Evaluation
- 1 June 2002
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 167 (6) , 2427-2434
- https://doi.org/10.1016/s0022-5347(05)64998-1
Abstract
Conclusions These results demonstrate that in a prospective setting with long-term followup free PSA strategies can be identified that decrease unnecessary biopsies, while preserving or even improving cancer detection. Thus, total and free PSA can be combined without the need to weigh subjectively the trade-offs and relative costs of false-negative and false-positive results.Keywords
This publication has 26 references indexed in Scilit:
- Lowering PSA cutoffs to enhance detection of curable prostate cancerUrology, 2000
- Prostate-specific antigen: current statusCA: A Cancer Journal for Clinicians, 1999
- Cancer Surveillance Series: Interpreting Trends in Prostate Cancer Part III: Quantifying the Link Between Population Prostate-Specific Antigen Testing and Recent Declines in Prostate Cancer MortalityJNCI Journal of the National Cancer Institute, 1999
- Use of the Percentage of Free Prostate-Specific Antigen to Enhance Differentiation of Prostate Cancer From Benign Prostatic DiseaseJAMA, 1998
- Determination of the “reflex range” and appropriate cutpoints for percent free prostatespecific antigen in 413 men referred for prostatic evaluation using the AxSYM systemUrology, 1997
- Analysis of percent free prostate-specific antigen (PSA) for prostate cancer detection: Influence of total psa, prostate volume, and ageUrology, 1996
- Using proportions of free to total prostate-specific antigen, age, and total prostate-specific antigen to predict the probability of prostate cancerUrology, 1996
- Free to total prostate-specific antigen (PSA) ratio is superior to total-PSA in differentiating benign prostate hypertrophy from prostate cancerThe Prostate, 1996
- Serial Prostatic Biopsies in Men with Persistently Elevated Serum Prostate Specific Antigen ValuesJournal of Urology, 1994
- Alpha1-antichymotrypsin production in PSA-producing cells is common in prostate cancer but rare in benign prostatc hyperplasiaUrology, 1994